BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? World J Clin Oncol 2014; 5(2): 71-81 [PMID: 24829853 DOI: 10.5306/wjco.v5.i2.71]
URL: https://www.wjgnet.com/1948-5182/full/v5/i2/71.htm
Number Citing Articles
1
Wei Zhao, Chang-You Yin, Jing Jiang, Wei Kong, Hao Xu, Hongtao Zhang. MicroRNA-153 suppresses cell invasion by targeting SNAI1 and predicts patient prognosis in gliomaOncology Letters 2018;  doi: 10.3892/ol.2018.9706
2
Steven L. Wood, Janet E. Brown. Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone MetastasesCancers 2020; 12(8): 2109 doi: 10.3390/cancers12082109
3
YING JIN, MIN ZHAO, QIAN XIE, HONGYAN ZHANG, QING WANG, QINGJIE MA. MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4International Journal of Oncology 2015; 47(4): 1594 doi: 10.3892/ijo.2015.3114
4
Chiara de Santi, Catherine M. Greene. MicroRNAs and Other Non-Coding RNAs in Inflammation2015; : 3 doi: 10.1007/978-3-319-13689-9_1
5
Nihad Al-Othman, Ala’ Alhendi, Manal Ihbaisha, Myassar Barahmeh, Moath Alqaraleh, Bayan Z. Al-Momany. Role of CD44 in breast cancerBreast Disease 2020; 39(1): 1 doi: 10.3233/BD-190409
6
Chun-yao Li, Dan-dan Xiong, Chun-qin Huang, Rong-quan He, Hai-wei Liang, Deng-hua Pan, Han-lin Wang, Yi-wen Wang, Hua-wei Zhu, Gang Chen. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and BioinformaticsMedical Science Monitor 2017; 23: 1857 doi: 10.12659/MSM.900030
7
Richard Ming Chuan Yu, Yoke Kqueen Cheah. The roles of miRNAs in human breast cancer and canine mammary tumorApplied Cancer Research 2017; 37(1) doi: 10.1186/s41241-017-0043-7
8
Lihong Wang, Wen Wang, Yuanyuan Wu. MicroRNA‑26b acts as an antioncogene and prognostic factor in cervical cancerOncology Letters 2019;  doi: 10.3892/ol.2019.9965
9
Bing Liu, Ming Lan, Huali Wei, Dapeng Zhang, Junmeng Liu, Jiwei Teng. Downregulated microRNA‑133a induces HUVECs injury: Potential role of the (pro) renin receptor in angiotensin�II‑dependent hypertensionMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10519
10
Shiza Malik, Samra Khalid, Haidar Ali, Maham Khan, Faryal Mehwish, Aneela Javed, Fazal Akbar, Rumeza Hanif, Muhammad Suleman. In-silico modeling and analysis of the therapeutic potential of miRNA-7 on EGFR associated signaling network involved in breast cancerGene Reports 2020; 21: 100938 doi: 10.1016/j.genrep.2020.100938
11
Thalia Erbes, Marc Hirschfeld, Gerta Rücker, Markus Jaeger, Jasmin Boas, Severine Iborra, Sebastian Mayer, Gerald Gitsch, Elmar Stickeler. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarkerBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1190-4
12
Geraldine Cizeron-Clairac, François Lallemand, Sophie Vacher, Rosette Lidereau, Ivan Bieche, Celine Callens. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1505-5
13
Jennifer Y. Y. Kwan, Pamela Psarianos, Jeff P. Bruce, Kenneth W. Yip, Fei-Fei Liu. The complexity of microRNAs in human cancerJournal of Radiation Research 2016; 57(S1): i106 doi: 10.1093/jrr/rrw009
14
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, Sotiria Psallida, Maria Dalamaga. The Role of Adipokines in Breast Cancer: Current Evidence and PerspectivesCurrent Obesity Reports 2019; 8(4): 413 doi: 10.1007/s13679-019-00364-y
15
Claudia Cava, Antonio Colaprico, Gloria Bertoli, Gianluca Bontempi, Giancarlo Mauri, Isabella Castiglioni. How interacting pathways are regulated by miRNAs in breast cancer subtypesBMC Bioinformatics 2016; 17(S12) doi: 10.1186/s12859-016-1196-1
16
Hongsheng Han, Zhenxian Zhang, Xueqin Yang, Wenfeng Yang, Chengwei Xue, Xiaoli Cao. miR‑23b suppresses lung carcinoma cell proliferation through CCNG1Oncology Letters 2018;  doi: 10.3892/ol.2018.9181
17
Maria Dalamaga, Gerasimos Socrates Christodoulatos. Adipocytokines, Energy Balance, and CancerEnergy Balance and Cancer 2017; 12: 109 doi: 10.1007/978-3-319-41677-9_6
18
K. A. Grishina, V. A. Khaylenko, D. V. Khaylenko, A. V. Karpukhin. Role of microRNAs in breast cancer development and their potential as biomarkersTumors of female reproductive system 2018; 14(3): 40 doi: 10.17650/1994-4098-2018-14-3-40-47
19
Shantanu Girotra, Kristina Yeghiazaryan, Olga Golubnitschaja. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnosticsPersonalized Medicine 2016; 13(5): 469 doi: 10.2217/pme-2016-0020
20
Showkat Ahmad Bhat, Sabhiya Majid, Hilal Ahmad Wani, Samia Rashid. Diagnostic utility of epigenetics in breast cancer – A reviewCancer Treatment and Research Communications 2019; 19: 100125 doi: 10.1016/j.ctarc.2019.100125
21
Jun Chu. MicroRNA‑589 serves as a tumor suppressor microRNA through directly targeting metastasis‑associated protein 2 in breast cancerOncology Letters 2019;  doi: 10.3892/ol.2019.10548
22
Lei Huo, Yan Wang, Yun Gong, Savitri Krishnamurthy, Jing Wang, Lixia Diao, Chang-Gong Liu, Xiuping Liu, Feng Lin, William F Symmans, Wei Wei, Xinna Zhang, Li Sun, Ricardo H Alvarez, Naoto T Ueno, Tamer M Fouad, Kenichi Harano, Bisrat G Debeb, Yun Wu, James Reuben, Massimo Cristofanilli, Zhuang Zuo. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerModern Pathology 2016; 29(4): 330 doi: 10.1038/modpathol.2016.38
23
Elif Demirdogen Sevinc, Gulsah Cecener, Secil Ak, Berrin Tunca, Unal Egeli, Sehsuvar Gokgoz, Sahsine Tolunay, Ismet Tasdelen. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancerGene 2016; 590(2): 278 doi: 10.1016/j.gene.2016.05.033
24
Virginie Armand-Labit, Anne Pradines. Circulating cell-free microRNAs as clinical cancer biomarkersBiomolecular Concepts 2017; 8(2): 61 doi: 10.1515/bmc-2017-0002
25
Imen Medimegh, Ines Omrane, Maud Privat, Nancy Uhrhummer, Hajer Ayari, Fadoua Belaiba, Farhat Benayed, Khaled Benromdhan, Sylvie Mader, Ives-Jean Bignon, Amel Benammar Elgaaied, Pranela Rameshwar. MicroRNAs Expression in Triple Negative vs Non Triple Negative Breast Cancer in Tunisia: Interaction with Clinical OutcomePLoS ONE 2014; 9(11): e111877 doi: 10.1371/journal.pone.0111877
26
Olga Golubnitschaja, Manuel Debald, Kristina Yeghiazaryan, Walther Kuhn, Martin Pešta, Vincenzo Costigliola, Godfrey Grech. Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measuresTumor Biology 2016; 37(10): 12941 doi: 10.1007/s13277-016-5168-x
27
Xuan Zou, Minghui Li, Zebo Huang, Xin Zhou, Qingxie Liu, Tiansong Xia, Wei Zhu. Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancerGene 2020; 722: 144104 doi: 10.1016/j.gene.2019.144104
28
F Peng, Y Zhang, R Wang, W Zhou, Z Zhao, H Liang, L Qi, W Zhao, H Wang, C Wang, Z Guo, Y Gu. Identification of differentially expressed miRNAs in individual breast cancer patient and application in personalized medicineOncogenesis 2016; 5(2): e194 doi: 10.1038/oncsis.2016.4
29
Menha Swellam, Amal Ramadan, Enas A. El‐Hussieny, Noha M. Bakr, Naglaa M. Hassan, Mohamed Emam Sobeih, Lobna R. EzzElArab. Clinical significance of blood‐based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markersJournal of Cellular Biochemistry 2019; 120(8): 12321 doi: 10.1002/jcb.28496
30
Clémence Basse, Michel Arock. The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatmentInternational Journal of Cancer 2015; 137(12): 2785 doi: 10.1002/ijc.29347
31
Maria Dalamaga, Gerasimos Socrates Christodoulatos, Christos S. Mantzoros. The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challengesMetabolism 2018; 82: 72 doi: 10.1016/j.metabol.2018.01.001
32
Dong Guo, Jia Guo, Xiang Li, Feng Guan. Enhanced motility and proliferation by miR‑10b/FUT8/p‑AKT axis in breast cancer cellsOncology Letters 2018;  doi: 10.3892/ol.2018.8891
33
Ting-Yu Chang, Hsin-An Chen, Ching-Feng Chiu, Yi-Wen Chang, Tsang-Chih Kuo, Po-Chun Tseng, Weu Wang, Mien-Chie Hung, Jen-Liang Su. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXLCancer Research 2016; 76(13): 3916 doi: 10.1158/0008-5472.CAN-15-2555
34
Onder Yumrutas, Serdar Oztuzcu, Hakan Büyükhatipoglu, Ibrahim Bozgeyik, Esra Bozgeyik, Yusuf Ziya Igci, Haydar Bagis, M. Ozgur Cevik, M. Emin Kalender, Zeynep Eslik, Ahmet Arslan. The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancerTumor Biology 2015; 36(6): 4427 doi: 10.1007/s13277-015-3082-2
35
Andrew McGuire, James A. L. Brown, Michael J. Kerin. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoringCancer and Metastasis Reviews 2015; 34(1): 145 doi: 10.1007/s10555-015-9551-7
36
Yuan Li, Yan Li, Changzhi Huang. Cancer and Noncoding RNAs2018; : 79 doi: 10.1016/B978-0-12-811022-5.00005-X
37
Andrew McGuire, James Brown, Carmel Malone, Ray McLaughlin, Michael Kerin. Effects of Age on the Detection and Management of Breast CancerCancers 2015; 7(2): 908 doi: 10.3390/cancers7020815